Compare ICUI & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICUI | WAY |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.8B |
| IPO Year | 1995 | 2023 |
| Metric | ICUI | WAY |
|---|---|---|
| Price | $155.95 | $22.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 17 |
| Target Price | ★ $169.00 | $36.59 |
| AVG Volume (30 Days) | 282.9K | ★ 3.0M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.62 | ★ 569.23 |
| EPS | ★ 1.20 | 0.22 |
| Revenue | ★ $2,231,262,000.00 | $1,099,278,000.00 |
| Revenue This Year | N/A | $18.26 |
| Revenue Next Year | $4.46 | $10.62 |
| P/E Ratio | $130.43 | ★ $105.36 |
| Revenue Growth | N/A | ★ 16.50 |
| 52 Week Low | $107.02 | $17.26 |
| 52 Week High | $162.18 | $39.99 |
| Indicator | ICUI | WAY |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 64.32 |
| Support Level | $146.59 | $21.03 |
| Resistance Level | $160.09 | $26.73 |
| Average True Range (ATR) | 5.21 | 0.99 |
| MACD | 0.74 | 0.54 |
| Stochastic Oscillator | 79.15 | 78.93 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.